2024-04-17 2025-04-30 false No description of principal activity Capium Accounts Production 1.1 SC807266 2024-04-17 2025-04-30 SC807266 bus:FullAccounts 2024-04-17 2025-04-30 SC807266 bus:Micro-entities 2024-04-17 2025-04-30 SC807266 bus:AuditExempt-NoAccountantsReport 2024-04-17 2025-04-30 SC807266 bus:SmallCompaniesRegimeForAccounts 2024-04-17 2025-04-30 SC807266 bus:PrivateLimitedCompanyLtd 2024-04-17 2025-04-30 SC807266 2024-04-17 2025-04-30 SC807266 2025-04-30 SC807266 bus:RegisteredOffice 2024-04-17 2025-04-30 SC807266 core:WithinOneYear 2025-04-30 SC807266 core:AfterOneYear 2025-04-30 SC807266 1 2024-04-17 2025-04-30 SC807266 bus:Director1 2024-04-17 2025-04-30 SC807266 bus:Director1 2025-04-30 SC807266 2023-04-17 SC807266 bus:LeadAgentIfApplicable 2024-04-17 2025-04-30 SC807266 2024-04-16 SC807266 core:MotorCars 2024-04-17 2025-04-30 SC807266 core:MotorCars 2025-04-30 SC807266 core:MotorCars 2024-04-16 SC807266 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-04-30 SC807266 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-04-16 SC807266 core:CostValuation core:Non-currentFinancialInstruments 2025-04-30 SC807266 core:CostValuation core:Non-currentFinancialInstruments 2024-04-16 SC807266 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-04-30 SC807266 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-04-30 SC807266 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-04-30 SC807266 core:Non-currentFinancialInstruments 2025-04-30 SC807266 core:Non-currentFinancialInstruments 2024-04-16 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: SC807266
England and Wales

 

 

 

BELLEVUE MEDICAL DEVICES LTD



Unaudited Financial Statements
 


Period of accounts

Start date: 17 April 2024

End date: 30 April 2025
Director Gordon Machray
Registered Number SC807266
Registered Office SUITE 1 ANDOR HOUSE
PENTLAND PARK
GLENROTHES
FIFE
KY6 2AG
1
  2025
    £ £
Fixed assets   6,721 
Current assets 6,944   
Creditors: amount falling due within one year (1,979)  
Net current assets   4,965 
Total assets less current liabilities   11,686 
Creditors: amount falling due after more than one year   (12,533)
Net assets   (847)
 

     
Capital and reserves   (847)
 
NOTES TO THE ACCOUNTS

General Information
BELLEVUE MEDICAL DEVICES LTD is a private company, limited by shares, registered in England and Wales, registration number SC807266, registration address SUITE 1 ANDOR HOUSE, PENTLAND PARK, GLENROTHES, FIFE, KY6 2AG.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Deferred taxation
Deferred tax is provided in full in respect of taxation deferred by timing differences between the treatment of certain items for taxation and accounting purposes. The deferred tax balance has not been discounted.
Dividends
Proposed dividends are only included as liabilities in the statement of financial position when their payment has been approved by the shareholders prior to the statement of financial position date.
Preference dividends
Where preference shares are classed as liabilities rather than equity any preference dividends paid are included in interest payable and similar charges within the income statement.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Motor Vehicles 25% Reducing Balance
Investment properties
Investment properties are properties held to earn rentals and/or for capital appreciation.
Investment properties should be recognised initially at cost and subsequently investment properties are measured at fair value. Gains and losses arising from changes in the fair value of investment properties are included in profit or loss in the period in which they arise.
Assets on finance lease and hire purchase
Assets held under finance lease or hire purchase contracts i.e. those contracts where substantially all the risks and rewards of ownership have passed to the company, are included in the appropriate category of tangible fixed assets and depreciated over the shorter of the lease term and their estimated expected useful lives.
Future obligations under such contracts are included in creditors net of the finance charge allocated to future periods.
Fixed asset investments
Fixed asset investments are stated at cost less provision for any permanent diminution in value.
Stocks
Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow moving items. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads.
Current asset investments
Current asset investments are stated at the lower of cost and net realisable value.
2.

Tangible fixed assets

Cost or valuation Motor Vehicles   Total
  £   £
At 17 April 2024  
Additions 8,961    8,961 
Disposals  
At 30 April 2025 8,961    8,961 
Depreciation
At 17 April 2024  
Charge for period 2,240    2,240 
On disposals  
At 30 April 2025 2,240    2,240 
Net book values
Closing balance as at 30 April 2025 6,721    6,721 
Opening balance as at 17 April 2024  


3.

Average number of employees

Average number of employees during the period was 1.


For the period ended 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's Responsibilities:
The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476.

The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the director on 15 December 2025 and were signed by:


--------------------------------
Gordon Machray
Director
2